Moderna CEO Bancel set for a soft landing as his golden parachute swells to $926Mnews2022-03-11T14:25:31+00:00March 11th, 2022|Fierce Pharma|
Pfizer’s softly, softly, COVID marketing approach continues with new drug adnews2022-03-11T12:28:34+00:00March 11th, 2022|Fierce Pharma|
Endo gets behind cheeky new campaign for cellulite shotnews2022-03-11T11:04:47+00:00March 11th, 2022|Fierce Pharma|
Fierce Pharma Asia—Legend CEO’s cell therapy ambitions; Indian pharmas’ awkward position; new Hutchmed CEOnews2022-03-11T09:55:28+00:00March 11th, 2022|Fierce Pharma|
Exact Sciences enlists Katie Couric for new commercial to promote Cologuard, colorectal cancer screeningnews2022-03-11T02:44:34+00:00March 11th, 2022|Fierce Pharma|
Why snackable digital experiences are the future of physician marketingnews2022-03-10T18:58:26+00:00March 10th, 2022|Fierce Pharma|
Zydus hit with trio of FDA observations at Indian injectables plantnews2022-03-10T16:02:54+00:00March 10th, 2022|Fierce Pharma|
AbbVie touts Qulipta chronic migraine win as Biohaven duel heats upnews2022-03-10T15:34:12+00:00March 10th, 2022|Fierce Pharma|
Pfizer is halting investment in Russia but not ending its business there. Should drugmakers pull out altogether?news2022-03-10T14:28:02+00:00March 10th, 2022|Fierce Pharma|
Novartis puts contract manufacturing ambitions on display with deal to produce Carisma’s cell therapynews2022-03-10T14:16:07+00:00March 10th, 2022|Fierce Pharma|
